|
|
Volumn 190, Issue 4, 2005, Pages 570-571
|
|
Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity
a,b
|
|
Author keywords
Antibodies; Aromatase inhibitors; Estrogen receptor; Monocyte mediated cytotoxicity
|
|
Indexed keywords
ANTIBODY;
AROMATASE INHIBITOR;
CANCER VACCINE;
CHROMIUM 51;
ESTROGEN;
ESTROGEN RECEPTOR;
FORMESTANE;
GLYCOPROTEIN;
GLYCOPROTEIN STN;
MUCIN 1;
PEPTIDE;
THERATOPE;
UNCLASSIFIED DRUG;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
BREAST CANCER;
CANCER CELL;
CANCER CELL CULTURE;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOLYSIS;
DRUG EFFECT;
DRUG MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
MONOCYTE;
OVARY CARCINOMA;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR UPREGULATION;
SENSITIVITY ANALYSIS;
SENSITIZATION;
STATISTICAL SIGNIFICANCE;
TARGET CELL DESTRUCTION;
TUMOR IMMUNITY;
ANDROSTENEDIONE;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CA-15-3 ANTIGEN;
CELL CYCLE PROTEINS;
CELL LINE, TUMOR;
FEMALE;
HUMANS;
MONOCYTES;
OVARIAN NEOPLASMS;
RECEPTORS, ESTROGEN;
|
|
EID: 24944546451
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjsurg.2005.06.013 Document Type: Conference Paper |
|
Times cited : (26)
|
|
References (5)
|
